Author:
Caulk Alexander W.,Soler Jose,Platt Manu O.,Gleason Rudolph L.
Funder
American Heart Association
Subject
Rehabilitation,Biomedical Engineering,Orthopedics and Sports Medicine,Biophysics
Reference39 articles.
1. Enhanced oxidative stress and increased mitochondrial mass during efavirenz-induced apoptosis in human hepatic cells;Apostolova;Br. J. Pharmacol.,2010
2. Population pharmacokinetics of efavirenz in an unselected cohort of HIV-1-infected individuals;Back;Clin. Pharmacokinet.,2006
3. Nonlinear pharmacokinetics of efavirenz (DMP-266), a potent HIV-1 reverse transcriptase inhibitor, in rats and monkeys;Balani;Drug Metab. Dispos.,1999
4. Inhibition of mitochondrial function by efavirenz increases lipid content in hepatic cells;Blas-Garcia;Hepatology,2010
5. Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study;Carr;Lancet,1999
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献